Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Cynosure
Company Monitoring Page for Cynosure
latest headlines for company on cafepharma
Hologic burns its aesthetics unit
EP Vantage
Thu, 11/21/19 - 10:43 am
Tags:
devices
,
medical aesthetics
,
M&A
,
Hologic
,
Cynosure
Medtech M&A: The 10 biggest deals so far in 2017
Mass Device
Thu, 06/29/17 - 09:45 pm
Tags:
devices
,
M&A
,
Abbott Labs
,
St. Jude Medical
,
Edwards Lifesciences
,
Valtech Cardio
,
Hologic
,
Cynosure
,
JNJ
,
Teleflex
,
Vascular Soltions
,
Cardinal Health
,
Medtronic
,
Becton Dickinson
,
CR Bard
,
Boston Scientific
,
Symetis
,
Integra LifeSciences
,
Codman Neuro
,
Stryker
,
Novadaq
Hologic to buy Cynosure for $1.65 bln
Yahoo/Reuters
Tue, 02/14/17 - 07:37 pm
Tags:
Hologic
,
Cynosure
,
M&A
,
devices
FDA clears next-gen tattoo removal laser from Cynosure
Mass Device
Wed, 05/25/16 - 11:33 am
Tags:
FDA
,
tattoo removal
,
Cynosure
,
devices
Investing In Increased Tattoo Removal With Cynosure
Seeking Alpha
Thu, 05/16/13 - 10:25 am
Tags:
tattoo removal
,
Cynosure
,
devices
Cynosure Receives FDA Clearance for PicoSure™, the First Picosecond Device to Remove Tattoos and Benign Pigmented Lesions
Yahoo/PRNewswire
Tue, 12/4/12 - 10:55 pm
Tags:
Cynosure
,
FDA
,
tattoo
This Metric Suggests You're Right to Own Cynosure.
Motley Fool
Wed, 09/12/12 - 10:10 pm
Tags:
Cynosure
Cynosure: Pioneering Aesthetic Laser Applications
Seeking Alpha
Thu, 09/6/12 - 08:33 pm
Tags:
Cynosure
,
laser
,
innovation
9 Rallying Healthcare Stocks Seeing Strong Sales Trends
Seeking Alpha
Sat, 08/4/12 - 11:32 am
Tags:
Cynosure
,
Human Genome Sciences
,
Alexion
,
Watson
,
The Medicines Company
,
Gilead Sciences
,
Medtox
,
Trinity Biotech
Cynosure Reports Record Revenues of $39.6 Million for the Second Quarter of 2012
Yahoo/PRNewswire
Tue, 07/24/12 - 10:00 am
Tags:
Cynosure
,
earnings
Is a Revenue Miss Coming for Cynosure?
Motley Fool
Tue, 05/15/12 - 06:53 pm
Tags:
Cynosure
,
earnings
Cynosure's Cellulaze Cellulite Laser Work Station Receives Korean Regulatory Approval
Yahoo/PRNewswire
Wed, 11/30/11 - 10:47 pm
Tags:
Cynosure
,
laser
,
Korea
,
regulatory
Cynosure Reports Financial Results for the Second Quarter of 2011
Yahoo/PRNewswire
Tue, 07/26/11 - 07:35 pm
Tags:
Cynosure
,
earnings
Cynosure Acquires Aesthetic Laser Business of HOYA ConBio
Yahoo/PRnewswire
Tue, 06/28/11 - 11:31 pm
Tags:
Cynosure
,
lasers
,
ConBio
Cynosure Elects Brian M. Barefoot to Board of Directors
Yahoo/PRnewswire
Wed, 06/8/11 - 12:54 pm
Tags:
Cynosure
,
Management
Cellulite: Cynosure touts regulatory wins for laser fat-removal products | Regulatory roundup
Mass Device
Wed, 05/18/11 - 06:40 pm
Tags:
cellulite
,
Cynosure
,
lasers
,
regulatory
Cynosure Receives Additional International Regulatory Approvals for New Cellulite Reduction Workstations
PRNewswire
Tue, 05/17/11 - 08:47 pm
Tags:
Cynosure
,
cellulite
Cynosure Passes This Key Test
The Motley Fool
Wed, 03/30/11 - 04:55 pm
Tags:
Cynosure
,
stocks
,
investors
Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products
Yahoo/PR Newswire
Tue, 03/15/11 - 02:03 pm
Tags:
Cynosure
,
lasers
,
Aesthetic Devices
,
Korea
,
cellulite
Cynosure narrows 4Q loss, as revenue climbs 16 pct
Yahoo/Associated Press
Tue, 02/15/11 - 09:57 pm
Tags:
Cynosure
,
revenues
,
investors
Pages
1
2
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.